ROTH-STARK FILINGS\2004\MAR 13G DOR BIOPHARMA

Company

SOLIGENIX, INC.

Filed

March 18, 2004

Accession Number

0000950138-04-000262

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →